This book assembles recent achievements in both basic research and clinical management in the field of hepatology, virology
and immunology. It provides up-to-date information for clinicians who can apply the relevant knowledge to their daily clinical
practice and for researchers who are interested in clinically orientated studies. The updated and detailed technology, state-of-the-art
treatment strategies provided in this book serve as references for clinicians and resident physicians in the daily management
of ACLF. The rationality and strategies for basic research as well as patient management in this book can also be a valuable
reference for other fatal and end stage liver diseases than HBV induced ACLF.
This Volume 2 has 6 chapters
and focuses on its diagnosis and management.